In our study we determined not only the number of monocyte subtypes: classical, intermediate and non-classical but also analyzed the expression of surfaces markers: CD62L, CD11c, CD18, HLA-DR on these three monocyte subpopulations and we found differences between NSCLC patients and healthy donors. This evidence concerns the gene ITGAX and non-small cell lung carcinoma.